RS52453B - MODULATION OF PROSTAGLANDIN / CYCLOOOXYGENASE METABOLIC ROUTES - Google Patents

MODULATION OF PROSTAGLANDIN / CYCLOOOXYGENASE METABOLIC ROUTES

Info

Publication number
RS52453B
RS52453B RS20120372A RSP20120372A RS52453B RS 52453 B RS52453 B RS 52453B RS 20120372 A RS20120372 A RS 20120372A RS P20120372 A RSP20120372 A RS P20120372A RS 52453 B RS52453 B RS 52453B
Authority
RS
Serbia
Prior art keywords
group
prostaglandin
modulation
metabolic pathways
hydrogen atom
Prior art date
Application number
RS20120372A
Other languages
English (en)
Serbian (sr)
Inventor
Ernst WĂśLFERT
Original Assignee
Hunter-Fleming Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunter-Fleming Limited filed Critical Hunter-Fleming Limited
Priority claimed from PCT/GB2007/004584 external-priority patent/WO2008065408A2/en
Publication of RS52453B publication Critical patent/RS52453B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RS20120372A 2006-11-30 2007-11-29 MODULATION OF PROSTAGLANDIN / CYCLOOOXYGENASE METABOLIC ROUTES RS52453B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86787306P 2006-11-30 2006-11-30
GB0623971A GB0623971D0 (en) 2006-11-30 2006-11-30 Modulation of prostaglandin/cyclooxygenase metabolic pathways
PCT/GB2007/004584 WO2008065408A2 (en) 2006-11-30 2007-11-29 Modulation of prostaglandin/cyclooxygenase metabolic pathways

Publications (1)

Publication Number Publication Date
RS52453B true RS52453B (en) 2013-02-28

Family

ID=37671641

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20120372A RS52453B (en) 2006-11-30 2007-11-29 MODULATION OF PROSTAGLANDIN / CYCLOOOXYGENASE METABOLIC ROUTES

Country Status (9)

Country Link
CN (1) CN101594861B (es)
DK (1) DK2097079T3 (es)
ES (1) ES2390182T3 (es)
GB (1) GB0623971D0 (es)
NZ (1) NZ577075A (es)
PT (1) PT2097079E (es)
RS (1) RS52453B (es)
RU (1) RU2448712C2 (es)
SI (1) SI2097079T1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI713972B (zh) * 2019-01-14 2020-12-21 大江生醫股份有限公司 改善呼吸道健康之益生菌株及其組合物與用途
TWI692359B (zh) * 2019-02-25 2020-05-01 大江生醫股份有限公司 乳酸菌的代謝產物及其用於護肺的用途
CN111777613A (zh) * 2019-04-03 2020-10-16 中国药科大学 嘧啶二酮并吲哚和吡啶酮并吲哚类化合物的制备及用途
CN113905732A (zh) * 2019-04-09 2022-01-07 纽罗比特科学有限公司 用于预防或治疗脊髓损伤或椎管狭窄的药物组合物
CN111394289B (zh) * 2019-12-20 2021-06-11 合肥康诺生物制药有限公司 一种基因工程菌及其应用，生产前列腺素e2的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2363984A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 3-hydroxy-7 -hydroxy steroids and 3-oxo-7 -hydroxy steroids
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
GB2378898A (en) * 2001-08-14 2003-02-26 Hunter Fleming Ltd Prophylactic and therapeutic use of hydroxysteroids
FR2829697B1 (fr) * 2001-09-14 2004-03-19 Mayoly Spindler Lab Derives 7-hydroxyles et 7-cetoniques des hormones steroides 3 beta-hydroxylees pour le traitement des maladies inflammatoires ou fonctionnelles de l'intestin

Also Published As

Publication number Publication date
CN101594861A (zh) 2009-12-02
GB0623971D0 (en) 2007-01-10
CN101594861B (zh) 2013-06-12
DK2097079T3 (da) 2012-10-01
RU2009124917A (ru) 2011-01-10
SI2097079T1 (sl) 2012-10-30
RU2448712C2 (ru) 2012-04-27
ES2390182T3 (es) 2012-11-07
NZ577075A (en) 2012-01-12
PT2097079E (pt) 2012-09-24

Similar Documents

Publication Publication Date Title
RS52435B (en) PROTEAZOMA INHIBITORS
RS51805B (en) FUNGICIDE COMPOSITIONS
TW200833675A (en) Nicotinamide derivatives
RS51280B (sr) Novi derivati hidantoina za tretman obstruktivnih bolesti dišnih puteva
HRP20060254A2 (en) Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases
BR112014003237A2 (pt) compostos de indazol, composições e métodos de uso
MX2010002820A (es) Analogos de tiazolidindiona para tratamiento de hipertension.
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
ECSP066383A (es) Derivados de 5-fenil-4-metil-tiazol-2-il-amina como inhibidores de enzimas de cinasa fosfatidilinositol 3 (pi3) para el tratamiento de enfermedades inflamatorias de las vías respiratorias
NZ591728A (en) Cephalosporin having catechol group
RS52245B (en) CYTOTOXIC AGENTS CONTAINING NEW TOMAIMYCIN DERIVATIVES AND THEIR THErapeutic Use
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
DE602005016929D1 (de) Liganden für den cannabinoidrezeptoren
ECSP088717A (es) Derivados de amina
IL198226A0 (en) 2-[l-phenyl-5-hydroxy-4alpha-methyl
EA200802213A1 (ru) Способы лечения заболеваний крови
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
ATE537175T1 (de) Neue piperazino-dihydrothienopyrimidin-derivate
MX2010004232A (es) Compuesto de indolina de pirimidilo.
MA30821B1 (fr) Derives de pyrazoline utiles comme antagonistes des recepteurs de mineralocorticoïdes
UA95766C2 (ru) Производные терфенила для лечения болезни альцгеймера
GEP20125389B (en) Substituted pyrazole and triazole compounds as ksp inhibitors
DE502005009091D1 (de) NEUE 2-SUBSTITUIERTE D-HOMO ESTRA-1,3,5(10)-TRIENE ALS INHIBITOREN DER 17ß-HYDROXYSTEROIDDEHYDROGENASE TYP 1
MX2009013885A (es) Derivados de quinolina fusionados utiles como moduladores de acido gamma-aminobutirico.